about
Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinomaClinical practice guideline on the optimal radiotherapeutic management of brain metastasesNeoadjuvant or adjuvant therapy for resectable esophageal cancer: a clinical practice guidelineCombined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline.Bisphosphonates for the relief of pain secondary to bone metastases.The treatment of depression in cancer patients: a systematic review.Online planning and delivery technique for radiotherapy of spinal metastases using cone-beam CT: image quality and system performance.The management of dyspnea in cancer patients: a systematic review.Semiautomatic vertebrae visualization, detection, and identification for online palliative radiotherapy of bone metastases of the spine.Phase I study of individualized stereotactic body radiotherapy of liver metastases.Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC.20 randomized trial.Palliative thoracic radiotherapy for lung cancer: a systematic review.Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy.Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases.TOPGEAR: a randomised phase III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer (an international, intergroup trial of the AGITG/TROG/EORTC/NCIC CTG).The treatment of lymphedema related to breast cancer: a systematic review and evidence summary.What is the Best Way to Produce Consensus and Buy in to Guidelines for Rectal Cancer?Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.Factors influencing the use of single vs multiple fractions of palliative radiotherapy for bone metastases: a 5-year review.Conformal radiotherapy in the adjuvant treatment of gastric cancer: Review of 82 cases.The Brain Metastases Symptom Checklist as a novel tool for symptom measurement in patients with brain metastases undergoing whole-brain radiotherapy.The use and toxicity of steroids in the management of patients with brain metastases.Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23.Accumulated Delivered Dose Response of Stereotactic Body Radiation Therapy for Liver Metastases.Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.Revisiting classification of pain from bone metastases as mild, moderate, or severe based on correlation with function and quality of life.Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline.Phase 1/2 Study of the Addition of Cisplatin to Adjuvant Chemotherapy With Image Guided High-Precision Radiation Therapy for Completely Resected Gastric Cancer.Defining patient-based minimal clinically important effect sizes: a study in palliative radiotherapy for painful unresectable pelvic recurrences from rectal cancer.In search of a dose-response relationship with radiotherapy in the management of recurrent rectal carcinoma in the pelvis: a systematic review.Pretreatment quality-of-life score is a better discriminator of oesophageal cancer survival than performance status.Baseline measure of health-related quality of life (Functional Assessment of Cancer Therapy-Esophagus) is associated with overall survival in patients with esophageal cancer.Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.Effect of Intensity Modulated Radiation Therapy With Concurrent Chemotherapy on Survival for Patients With Cervical Esophageal Carcinoma.Predictive model for survival in patients having repeat radiation treatment for painful bone metastases.Accuracy of survival prediction by palliative radiation oncologists.Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy.
P50
Q24245030-32669F60-7543-4A5E-9DF8-268214F1B09DQ24798845-D6089448-1FF4-4F29-B474-303AA4566A1CQ24799989-268198ED-9EBD-4875-81AE-295C9C71C3D6Q31133248-A0FCF813-0C70-43AE-BDB1-6E70B9A4286FQ32139406-12DFEC7C-64AD-4393-82F4-E9106D884BF7Q33261185-E5D65353-EF1A-4349-8E38-051BE61D9819Q33276734-24E3B1CF-9798-4C32-B14A-7A0A9C54436CQ33316118-930C6F8D-047B-4CCE-91E6-6F6FCDA9E539Q33320850-EF4DE5C3-735C-47BF-B18F-0C2C3D5745A1Q33383521-5FFE8AEC-CC09-4766-870D-59818F206E52Q33558041-CF751872-FC59-454C-B2E0-8899CDEF079DQ34551038-BAD6E14C-9155-45E2-9FDE-8891BBB5DF39Q34810290-501F0732-1E95-4641-8E84-1E7CB65C95D2Q34940071-29C79717-D0E1-4C8E-951D-5DC058343C76Q34962091-A5569D1F-6B6C-49F5-A93D-C7273BF0A102Q35062543-120AF48B-95D2-4B8A-B6EE-763A7F98E7EBQ35700920-27065B37-648D-420C-BBBD-13BE95F06F6EQ35750319-CBD40496-D83B-483A-8C92-FAE6B30F0636Q35931518-07101E53-7FE8-4EE9-92B3-57514C3C5B03Q36160476-4E651AD0-E522-4E35-B82F-418D89AE1FA7Q36252043-F238ED55-CA4D-4979-B667-537C58733677Q36454492-1439D093-51E1-4E83-83A7-5F385CAE39CAQ36989133-B09E173B-2C1A-4317-B68A-7C19255E35B9Q37078927-39A84D39-EDC9-4DE9-A294-89A7AD79DE49Q37998931-6566B8C8-803D-4B08-9765-D8D96AE7565CQ38380845-86547B26-162C-4C28-9B79-6687DA8340BEQ38605846-8B477518-1FB5-4E6D-B778-DCBD858D96D9Q38884005-69C9BDA3-F003-422C-97B0-B1DCE8173278Q38960922-19B5D78E-9247-450C-8DBF-67169C1CF196Q39166964-5F04E431-0605-4153-81ED-2003C4ACE559Q39286565-B547173F-76C9-4372-9191-AF1B82EF16AAQ39402171-39350C34-06B8-47FF-B66E-DC881564E608Q39451124-5795A1B9-0BBC-49D7-A93D-8BFF39CC7849Q39506841-FAE76D51-FA13-4111-B3A2-9966ECC4C692Q39887652-7D737643-91EC-48A1-A84D-3ADE72D6504EQ40215311-C2974FA4-D1D4-403E-94B3-80E66EF1337BQ40308722-FD00E41E-2FD6-40AF-B74E-5A5475DFC60CQ40377610-F7601D6B-7E2D-42AF-8482-88995BF8CFDAQ40446251-B8FE0B29-E10A-491E-9CA8-67A53B2F4817Q41477879-FEDBB011-1115-4583-B212-70C04944AFD9
P50
description
researcher ORCID ID = 0000-0001-7210-3330
@en
wetenschapper
@nl
name
Rebecca KS Wong
@ast
Rebecca KS Wong
@en
Rebecca KS Wong
@es
Rebecca KS Wong
@nl
Rebecca KS Wong
@pt
type
label
Rebecca KS Wong
@ast
Rebecca KS Wong
@en
Rebecca KS Wong
@es
Rebecca KS Wong
@nl
Rebecca KS Wong
@pt
prefLabel
Rebecca KS Wong
@ast
Rebecca KS Wong
@en
Rebecca KS Wong
@es
Rebecca KS Wong
@nl
Rebecca KS Wong
@pt
P108
P106
P1153
7402127094
P31
P496
0000-0001-7210-3330